A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 1998-12, Vol.66 (12), p.1682-1688
Hauptverfasser: Flechner, Stuart M., Avery, Robin K., Fisher, Rosemaree, Mastroianni, Barbara A., Papajcik, Doreen A., O'Malley, Kiaran J., Goormastic, Marlene, Goldfarb, David A., Modlin, Charles S., Novick, Andrew C.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1688
container_issue 12
container_start_page 1682
container_title Transplantation
container_volume 66
creator Flechner, Stuart M.
Avery, Robin K.
Fisher, Rosemaree
Mastroianni, Barbara A.
Papajcik, Doreen A.
O'Malley, Kiaran J.
Goormastic, Marlene
Goldfarb, David A.
Modlin, Charles S.
Novick, Andrew C.
description
doi_str_mv 10.1097/00007890-199812270-00019
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00007890_199812270_00019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1097_00007890_199812270_00019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1549-c4b0b8b7905d8ff4cac43d3f4255f2e4818bb9d689c157702ffe911a010414c33</originalsourceid><addsrcrecordid>eNo9kNFKwzAYhXOh4Jy-Q16gmjSpSS5DlnVhWVPSblhvSts1oChKe-XL-KzGTf1vDnwczg8fABCjO4wEu0fxGBcowUJwnKYMJZFgcQEWCFGcYELYFbie55eIM8LYAnxJ6GWxcjvzpFew9K4qtarNQUPlito7ayOuvZEWujV0PqZUjbLuYDw8aF_tqzPNZaHML187D1VTu53O5YnEUpwuN42Vj6aCpoAbk28Sb6ot3JpVoZv4QxZVaWVRQ6-VKY0u6grfgMvQvc7j7W8uwX6ta7VJrMuNkjYZcEZFMtAe9bxnAmVHHgIduoGSIwk0zbKQjpRj3vfi-MBF7DOG0hBGgXGHcNRCB0KWgJ93h-l9nqcxtB_T81s3fbYYtT9u2z-37b_b9uSWfANo32ML</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1</title><source>Journals@Ovid Complete</source><creator>Flechner, Stuart M. ; Avery, Robin K. ; Fisher, Rosemaree ; Mastroianni, Barbara A. ; Papajcik, Doreen A. ; O'Malley, Kiaran J. ; Goormastic, Marlene ; Goldfarb, David A. ; Modlin, Charles S. ; Novick, Andrew C.</creator><creatorcontrib>Flechner, Stuart M. ; Avery, Robin K. ; Fisher, Rosemaree ; Mastroianni, Barbara A. ; Papajcik, Doreen A. ; O'Malley, Kiaran J. ; Goormastic, Marlene ; Goldfarb, David A. ; Modlin, Charles S. ; Novick, Andrew C.</creatorcontrib><identifier>ISSN: 0041-1337</identifier><identifier>DOI: 10.1097/00007890-199812270-00019</identifier><language>eng</language><ispartof>Transplantation, 1998-12, Vol.66 (12), p.1682-1688</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1549-c4b0b8b7905d8ff4cac43d3f4255f2e4818bb9d689c157702ffe911a010414c33</citedby><cites>FETCH-LOGICAL-c1549-c4b0b8b7905d8ff4cac43d3f4255f2e4818bb9d689c157702ffe911a010414c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Flechner, Stuart M.</creatorcontrib><creatorcontrib>Avery, Robin K.</creatorcontrib><creatorcontrib>Fisher, Rosemaree</creatorcontrib><creatorcontrib>Mastroianni, Barbara A.</creatorcontrib><creatorcontrib>Papajcik, Doreen A.</creatorcontrib><creatorcontrib>O'Malley, Kiaran J.</creatorcontrib><creatorcontrib>Goormastic, Marlene</creatorcontrib><creatorcontrib>Goldfarb, David A.</creatorcontrib><creatorcontrib>Modlin, Charles S.</creatorcontrib><creatorcontrib>Novick, Andrew C.</creatorcontrib><title>A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1</title><title>Transplantation</title><issn>0041-1337</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9kNFKwzAYhXOh4Jy-Q16gmjSpSS5DlnVhWVPSblhvSts1oChKe-XL-KzGTf1vDnwczg8fABCjO4wEu0fxGBcowUJwnKYMJZFgcQEWCFGcYELYFbie55eIM8LYAnxJ6GWxcjvzpFew9K4qtarNQUPlito7ayOuvZEWujV0PqZUjbLuYDw8aF_tqzPNZaHML187D1VTu53O5YnEUpwuN42Vj6aCpoAbk28Sb6ot3JpVoZv4QxZVaWVRQ6-VKY0u6grfgMvQvc7j7W8uwX6ta7VJrMuNkjYZcEZFMtAe9bxnAmVHHgIduoGSIwk0zbKQjpRj3vfi-MBF7DOG0hBGgXGHcNRCB0KWgJ93h-l9nqcxtB_T81s3fbYYtT9u2z-37b_b9uSWfANo32ML</recordid><startdate>199812</startdate><enddate>199812</enddate><creator>Flechner, Stuart M.</creator><creator>Avery, Robin K.</creator><creator>Fisher, Rosemaree</creator><creator>Mastroianni, Barbara A.</creator><creator>Papajcik, Doreen A.</creator><creator>O'Malley, Kiaran J.</creator><creator>Goormastic, Marlene</creator><creator>Goldfarb, David A.</creator><creator>Modlin, Charles S.</creator><creator>Novick, Andrew C.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199812</creationdate><title>A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1</title><author>Flechner, Stuart M. ; Avery, Robin K. ; Fisher, Rosemaree ; Mastroianni, Barbara A. ; Papajcik, Doreen A. ; O'Malley, Kiaran J. ; Goormastic, Marlene ; Goldfarb, David A. ; Modlin, Charles S. ; Novick, Andrew C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1549-c4b0b8b7905d8ff4cac43d3f4255f2e4818bb9d689c157702ffe911a010414c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flechner, Stuart M.</creatorcontrib><creatorcontrib>Avery, Robin K.</creatorcontrib><creatorcontrib>Fisher, Rosemaree</creatorcontrib><creatorcontrib>Mastroianni, Barbara A.</creatorcontrib><creatorcontrib>Papajcik, Doreen A.</creatorcontrib><creatorcontrib>O'Malley, Kiaran J.</creatorcontrib><creatorcontrib>Goormastic, Marlene</creatorcontrib><creatorcontrib>Goldfarb, David A.</creatorcontrib><creatorcontrib>Modlin, Charles S.</creatorcontrib><creatorcontrib>Novick, Andrew C.</creatorcontrib><collection>CrossRef</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flechner, Stuart M.</au><au>Avery, Robin K.</au><au>Fisher, Rosemaree</au><au>Mastroianni, Barbara A.</au><au>Papajcik, Doreen A.</au><au>O'Malley, Kiaran J.</au><au>Goormastic, Marlene</au><au>Goldfarb, David A.</au><au>Modlin, Charles S.</au><au>Novick, Andrew C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1</atitle><jtitle>Transplantation</jtitle><date>1998-12</date><risdate>1998</risdate><volume>66</volume><issue>12</issue><spage>1682</spage><epage>1688</epage><pages>1682-1688</pages><issn>0041-1337</issn><doi>10.1097/00007890-199812270-00019</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1337
ispartof Transplantation, 1998-12, Vol.66 (12), p.1682-1688
issn 0041-1337
language eng
recordid cdi_crossref_primary_10_1097_00007890_199812270_00019
source Journals@Ovid Complete
title A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A07%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20RANDOMIZED%20PROSPECTIVE%20CONTROLLED%20TRIAL%20OF%20ORAL%20ACYCLOVIR%20VERSUS%20ORAL%20GANCICLOVIR%20FOR%20CYTOMEGALOVIRUS%20PROPHYLAXIS%20IN%20HIGH-RISK%20KIDNEY%20TRANSPLANT%20RECIPIENTS1&rft.jtitle=Transplantation&rft.au=Flechner,%20Stuart%20M.&rft.date=1998-12&rft.volume=66&rft.issue=12&rft.spage=1682&rft.epage=1688&rft.pages=1682-1688&rft.issn=0041-1337&rft_id=info:doi/10.1097/00007890-199812270-00019&rft_dat=%3Ccrossref%3E10_1097_00007890_199812270_00019%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true